Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
复制标题
DOI:
10.1371/journal.pntd.0002303
复制
发表时间:
2013
影响因子:
3.8
通讯作者:
West SK
中科院分区:
文献类型:
--
作者:
Liu F;Porco TC;Ray KJ;Bailey RL;Mkocha H;Muñoz B;Quinn TC;Lietman TM;West SK
Trachoma programs have dramatically reduced the prevalence of the ocular chlamydia that cause the disease. Some have hypothesized that immunity to the infection may be reduced because of program success in reducing the incidence of infection, and transmission may then increase. Longitudinal studies of multiple communities would be necessary to test this hypothesis. Here, we quantify transmission using an estimated basic reproduction number based on 32 communities during the first, second, and third years of an antibiotic treatment program. We found that there is little to no increase in the basic reproduction number over time. The estimated linear trend in the basic reproduction number, , was found to be −0.025 per year, 95% CI −0.167 to 0.117 per year. We are unable to find evidence supporting any loss of immunity over the course of a 3-year program. This is encouraging, as it allows the possibility that repeated mass antibiotic distributions may eliminate infection from even the most severely affected areas. Trachoma, caused by repeated infections by the ocular strains of Chlamydia trachomatis, is the most common infectious cause of blindness in the world. Treatment for trachoma includes mass azithromycin treatments to the entire community. To reduce the prevalence of infection, the World Health Organization (WHO) advocates at least three annual community-wide distributions of oral antibiotics in affected areas, with further mass treatments based on the prevalence of trachoma. Trachoma programs have dramatically reduced the community prevalence of infection, and some have argued that lowered prevalence of infection may lead to reductions in immunity, and that less immunity may in turn lead to increased transmission from what infection remains. Here, we used a stochastic transmission model to analyze data collected from a 3-year antibiotic treatment program (a 32-community, cluster-randomized clinical trial in Tanzania) to assess whether or not transmission actually increases during elimination campaigns. We found no evidence supporting any increase in transmission over the course of the program. The absence of a short term increase in transmission as the prevalence decreases is good news for trachoma programs.
登录
查看更多内容
影响因子:
168.9
作者:
West, SK;Munoz, B;Mabey, DCW
通讯作者:
Mabey, DCW
影响因子:
120.7
作者:
Chidambaram, JD;Alemayehu, W;Lietman, TM
通讯作者:
Lietman, TM
影响因子:
3.8
作者:
Harding-Esch, Emma M.;Edwards, Tansy;Mkocha, Harran;Munoz, Beatriz;Holland, Martin J.;Burr, Sarah E.;Sillah, Ansumana;Gaydos, Charlotte A.;Stare, Dianne;Mabey, David C. W.;Bailey, Robin L.;West, Sheila K.
通讯作者:
West, Sheila K.
影响因子:
120.7
作者:
Atik, Berna;Thanh, Ton Ton Kim;Dean, Deborah
通讯作者:
Dean, Deborah
影响因子:
168.9
作者:
Schachter, J;West, SK;Faal, H
通讯作者:
Faal, H